Method for determining one of the two Human Immunodeficiency Virus (HIV) integrase enzymatic activities

Details for Australian Patent Application No. 2008333164 (hide)

Owner Tibotec Pharmaceuticals

Inventors Van Loock, Marnix; Meersseman, Geert Henri

Agent Shelston IP

Pub. Number AU-A-2008333164

PCT Pub. Number WO2009/071649

Priority 07122467.9 06.12.07 EP

Filing date 5 December 2008

Wipo publication date 11 June 2009

International Classifications

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/071649 Priority application(s): WO2009/071649

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333165-Amide compounds as boosters of antivirals

2008333153-Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane6-sulfonic acid derivatives